Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-05

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to use multi-omics testing on samples collected from Mayo Clinic patients to build and expand on what has been learned about genomic data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

NCT02612350

Mutation Neoplasms

COMPLETED

A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing

NCT02705404

Lung Neoplasms Carcinoma Non-small-cell Lung

TERMINATED

Concordance Between ctDNA Assay and FoundationOne

NCT02620527

Circulating Tumor DNA Cancer Neoplasms +2 more

COMPLETED

Microarray Analysis for Human Genetic Disease

NCT00001898

Breast Neoplasm Hereditary Neoplastic Syndrome Melanoma +1 more

COMPLETED

Multi-Cancer Detection Observational Cohort Study

NCT06962995

Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Genetic Predisposition Exposure, Environmental

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suspected Genetic Predisposition or Multi-Omics Contribution

Patients with a diagnosis or phenotype with the potential for association with a genetic predisposition or Multi-Omics Contribution.

No interventions assigned to this group

Healthy Control

Patients with no diagnosis associated with a genetic predisposition or Multi-Omics Contribution.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Registered Mayo Clinic patient
* Able to provide informed written consent
* Able to receive mail and packages within a United States (US) state
* Able to collect and ship samples within a US state

Exclusion Criteria

* Active hematological cancer or history of a hematological cancer
* Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
* Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No